Rani Therapeutics Partners with Chugai in $1 Billion Deal for Oral Biologics

Rani Therapeutics has entered a significant potential $1 billion deal with Chugai Pharmaceutical to develop oral biologics. This partnership is expected to enhance drug delivery systems, making biologic medications more accessible. Investors are optimistic about the collaboration, which could lead to groundbreaking advancements in the pharmaceutical industry and improve patient care for chronic diseases.